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It  has been recently discovered that  microRNAs are stably expressed in  body fluids of several 
organisms and that the expression patterns in the plasma/serum of cancer patients could represent a 
diagnostic/predictive tool of the disease. Extracellular miRNAs have been also found in the growth 
medium of cells in culture and this prompted us to verify whether prostate tumor cell lines release 
miRNAs specific  of prostate  tumor patients and whether anticancer  drugs affect the expression 
patterns of the extracellular miRNAs. First of all we determined the expression of either prostate 
specific (PS-miRNA) or non prostate specific (NPS-miRNA) miRNAs in the growth medium of 
PC3 and DU-145 cells (prostate metastatic tumor cell lines) in comparison to PNT1A (immortalized 
prostate cell line). We found that the levels of both the intracellular and extracellular PS-miRNAs 
were  higher  in  PC3 and DU-145  tumor cell  lines  in  comparison to  the  immortalized  cell  line 
PNT1A and that a positive correlation exists between the intracellular and the extracellular levels 
suggesting that the release of miRNA in the growth medium may be a manner to maintain the  
intracellular  miRNAs at  physiological  level.  Thereafter,  we investigated  whether  the  release  of 
miRNAs is affected in cells upon their exposure to a cytotoxic drug. To address the point, PC-3 and 
DU-145  cells  were  exposed  to  a  cytotoxic  concentration  of  either  fludarabine  (10  μg/mL)  or 
taxotere (30 nM) for 48 hours. At the end of the treatment both the intracellular and extracellular 
PS-miRNAs and NPS-miRNAs were quantified. Data showed that  i) those miRNAs that were up 
regulated in cells surviving to either fludarabine or taxotere were not released and that ii) the up 
regulated miRNAs found in fludarabine-or in taxotere-surviving cells were not the same. Overall 
data indicate for the first time a possible involvement of miRNAs in the survival/resistance of tumor  
cells to cytotoxic drugs and suggest that the expression pattern of the intracellular and extracellular 
miRNAs  could  be  an  useful  tool  to  identify  in  tumor  cell  lines  miRNAs  responsible  of 
survival/resistance to cytotoxic drugs and in plasma/serum of cancer patients the efficacy of an 
anticancer treatment.
